MDM2 and melanoma: A number of mechanisms for inhibition of P53 function in melanoma cells have been suggested, such as de-regulation of MDM2 and MDM4, over-expression of Y box-binding protein 1 (YB-1), loss of P53 adaptor proteins [19,20] and our own studies have suggested that P53 isoforms may be involved [16].